Funder: Dept. of the Army -- USAMRAA
Due Dates: July 25, 2025 (Pre-application/LOI) | August 8, 2025 (Full application)
Funding Amounts: Up to $500,000 total costs per award over 2 years; approx. 5 awards; $2.5M total program funding.
Summary: Supports innovative, high-risk/high-reward research to accelerate progress in Duchenne muscular dystrophy (DMD) therapy and outcomes.
Key Information: Preliminary DMD-relevant data required; clinical trials are not allowed; includes special categories for new investigators.